Canonical: https://neurodiversity.gklijs.tech/i/ba339eaab2f9

# Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates

The Manila Times

17 November 2026 (2026-11-17)

Firefly Neuroscience reported a 373% year-over-year increase in U18 ADHD Evoke™ scans, driven by growing clinical adoption and commercial expansion. The company is leveraging its nationwide network to cross-sell non-drug ADHD treatments, aiming to create an end-to-end diagnostic-to-treatment model. The surge in scans also enhances Firefly's AI foundation through its expanding proprietary dataset of over 200,000 brain scans.

[Read at The Manila Times](<https://www.manilatimes.net/2026/11/17/tmt-newswire/globenewswire/firefly-neuroscience-reports-373-year-over-year-increase-in-u18-adhd-evoke-scans-as-commercial-expansion-accelerates/2472001>)

All articles from [17 November 2026](</2026/11/17>). Summaries are AI-generated and may contain errors; the linked article is the authority.

## Get this news by email

Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the [subscribe page](</subscribe>).

## More to read

- [Topics](</topics>)
- [Agenda](</agenda>)
- [Subscribe](</subscribe>)
